270 related articles for article (PubMed ID: 27909192)
1. The more the merrier? Scoring, statistics and animal welfare in experimental autoimmune encephalomyelitis.
Palle P; Ferreira FM; Methner A; Buch T
Lab Anim; 2016 Dec; 50(6):427-432. PubMed ID: 27909192
[TBL] [Abstract][Full Text] [Related]
2. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
3. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
5. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
6. The experimental autoimmune encephalomyelitis model for proteomic biomarker studies: from rat to human.
Rosenling T; Attali A; Luider TM; Bischoff R
Clin Chim Acta; 2011 May; 412(11-12):812-22. PubMed ID: 21333641
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.
Emerson MR; Gallagher RJ; Marquis JG; LeVine SM
Comp Med; 2009 Apr; 59(2):112-28. PubMed ID: 19389303
[TBL] [Abstract][Full Text] [Related]
8. Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
Tietz SM; Zwahlen M; Haghayegh Jahromi N; Baden P; Lazarevic I; Enzmann G; Engelhardt B
Eur J Immunol; 2016 Oct; 46(10):2481-2483. PubMed ID: 27469626
[TBL] [Abstract][Full Text] [Related]
9. Neuropathological Techniques to Investigate CNS Pathology in Experimental Autoimmune Encephalomyelitis (EAE).
Steinbach K; Merkler D
Methods Mol Biol; 2016; 1304():189-209. PubMed ID: 25146304
[TBL] [Abstract][Full Text] [Related]
10. Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.
Shalaby SM; Sabbah NA; Saber T; Abdel Hamid RA
IUBMB Life; 2016 Feb; 68(2):106-15. PubMed ID: 26757144
[TBL] [Abstract][Full Text] [Related]
11. Induction and clinical scoring of chronic-relapsing experimental autoimmune encephalomyelitis.
Beeton C; Garcia A; Chandy KG
J Vis Exp; 2007; (5):224. PubMed ID: 18979022
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
Stojkov D; Lavrnja I; Pekovic S; Dacic S; Bjelobaba I; Mostarica-Stojkovic M; Stosic-Grujicic S; Jovanovic S; Nedeljkovic N; Rakic L; Stojiljkovic M
J Neurol Sci; 2008 Apr; 267(1-2):76-85. PubMed ID: 17996253
[TBL] [Abstract][Full Text] [Related]
13. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
14. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
15. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
16. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis.
Sriram S; Steiner I
Ann Neurol; 2005 Dec; 58(6):939-45. PubMed ID: 16315280
[TBL] [Abstract][Full Text] [Related]
17. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.
Smith ME; Eller NL; McFarland HF; Racke MK; Raine CS
Am J Pathol; 1999 Oct; 155(4):1147-61. PubMed ID: 10514398
[TBL] [Abstract][Full Text] [Related]
18. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
Allameh A; Maleklou N; Zargari M; Sanati MH
Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
[TBL] [Abstract][Full Text] [Related]
19. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
[TBL] [Abstract][Full Text] [Related]
20. Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
Wolfensohn S; Hawkins P; Lilley E; Anthony D; Chambers C; Lane S; Lawton M; Voipio HM; Woodhall G
J Pharmacol Toxicol Methods; 2013; 67(3):169-76. PubMed ID: 23357188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
